Non-Hodgkin Lymphoma | Tumor

CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.

First Patient Receives Investigational CAR-T Cell Therapy in Trial Assessing the Treatment for Lymphoma, Leukemia

October 14th 2022, 9:00pm

Article

Investigators of an expanded clinical trial have administered an investigational CAR-T cell therapy to the first patient with blood cancer.

Jane Fonda Provides a Cancer Update, Old News Clipping Helps Patient With Leukemia Benefit from the Sept. 11 Victim Fund and More

September 9th 2022, 3:00pm

Article

From actress Jane Fonda giving an update on her cancer, to a patient with leukemia proving he was at the Sept. 11 attacks in New York City with an old newspaper clipping, here’s what’s happening in the cancer space this week.

FDA to Speed Up Review of Novel CAR-T Cell Therapy for Rare Forms of Lymphoma and Leukemia

July 19th 2022, 9:00pm

Article

A first-in-human trial is investigating the safety and efficacy of the novel CAR-T cell therapy in patients relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.

4 Recent FDA-Approved Blood Cancer Drugs That Patients May Have Missed

June 28th 2022, 7:00pm

Article

Spring 2022 brought in some landmark blood cancer approvals from the FDA. Here is a roundup of the therapies recently approved by the FDA that patients may have missed.

Robin Roberts Provides an Update on Her Partner’s Cancer, Supreme Court Rejects Bayer’s Roundup Appeals and More

June 24th 2022, 3:00pm

Article

From Robin Roberts’ personal message about her partner, Amber Laign’s cancer, to a dancing group inspired by an “America’s Got Talent” contestant who died of cancer, here’s what is happening in the cancer space this week.

Two-Drug Combo Elicits Similar Outcomes to Standard of Care in Young Patients With Non-Hodgkin Lymphoma

May 11th 2022, 9:00pm

Article

The use of bendamustine and Rituxan plus autologous stem cell transplantation and maintenance Rituxan resulted in similar outcomes to other Rituxan-based regimens that are currently the standard of care for young patients with mantle cell lymphoma, a type of non-Hodgkin lymphoma, who are eligible for transplant.

Targeted Therapies Shake up the DLBCL Treatment Paradigm, Expert Says

February 25th 2022, 9:02pm

Article

An expert gives an overview of current standard of care and what’s coming down the pipeline in terms of treatment options for diffuse large B-cell lymphoma.

Experimental Lymphoma Drug Shows ‘Robust Clinical Activity,’ Researchers Say

February 25th 2022, 2:00pm

Article

Treatment with TRPH-222 led to lasting responses in certain patients with relapsed/refractory B-cell non-Hodgkin lymphomas, warranting a larger investigation into the drug, according to the researchers.

Did Surviving Cancer Flip the Script on How I Was Treated on Social Media?

February 23rd 2022, 8:00pm

Article

Nina Luker has shared her journey with diffuse large B-cell lymphoma on social media with more than 100,000 followers, but says she noticed a difference in the kinds of comments she received after treatment was over and she was deemed “not as vulnerable” anymore.

Snowboarder Max Parrot Wins Olympic Gold 3 Years After Cancer Diagnosis, ‘Modern Family’ Star Sofía Vergara Openly Discusses Cancer Survivorship

February 11th 2022, 4:00pm

Article

From an Olympic gold medal win for cancer survivor Max Parrot to Sofía Vergara’s candidness about her cancer journey, here’s what’s happening in the cancer landscape this week.